# Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus

> **NCT00286494** · PHASE3 · COMPLETED · sponsor: **Takeda** · enrollment: 493 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Alogliptin and pioglitazone
- **DRUG:** Alogliptin and pioglitazone
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00286494
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2012-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00286494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00286494, "Study of Alogliptin Combined With Pioglitazone in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00286494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*